Ascendis Pharma A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.65375
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, ...

226.80 -2.21 (-0.97%)

82.81% Gain from 52W Low

108.1K

XNAS Volume

XNAS 13 Mar, 2026 10:50 AM (EDT)

Not Eligible

Expensive Valuation

6.0 / 100

Technically Moderately Bullish

60.2 / 100

286

1Yr Price target upside is 26%

16 analysts

Ascendis Pharma A/S (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..